Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $11.06 Average PT from Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has earned an average recommendation of “Moderate Buy” from the eleven research firms that are covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $11.0625.

Several analysts recently issued reports on AVAH shares. William Blair started coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating on the stock. Zacks Research upgraded shares of Aveanna Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 price target on shares of Aveanna Healthcare in a research report on Friday, December 5th. Barclays upped their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Finally, UBS Group boosted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a report on Thursday, January 15th.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, insider Edwin C. Reisz sold 17,613 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $138,262.05. Following the completion of the transaction, the insider directly owned 1,321,114 shares in the company, valued at $10,370,744.90. The trade was a 1.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jeff Shaner sold 29,357 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $230,452.45. Following the transaction, the chief executive officer directly owned 2,394,179 shares of the company’s stock, valued at $18,794,305.15. This trade represents a 1.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 259,638 shares of company stock valued at $2,109,595. Corporate insiders own 7.80% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Dynamic Technology Lab Private Ltd increased its holdings in shares of Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after acquiring an additional 1,151 shares during the period. Barclays PLC grew its position in Aveanna Healthcare by 0.8% in the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after purchasing an additional 1,366 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Aveanna Healthcare by 4.5% in the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after purchasing an additional 1,528 shares during the period. Balboa Wealth Partners raised its holdings in shares of Aveanna Healthcare by 13.5% during the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after buying an additional 2,007 shares during the last quarter. Finally, Olympiad Research LP raised its holdings in shares of Aveanna Healthcare by 7.5% during the third quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock valued at $280,000 after buying an additional 2,200 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Stock Down 0.8%

Shares of Aveanna Healthcare stock opened at $8.92 on Friday. Aveanna Healthcare has a 1-year low of $3.67 and a 1-year high of $10.32. The company has a market capitalization of $1.86 billion, a PE ratio of 24.78 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The business has a 50-day moving average of $8.85 and a 200-day moving average of $7.88.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.08. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $621.94 million during the quarter, compared to the consensus estimate of $578.57 million. As a group, equities analysts forecast that Aveanna Healthcare will post -0.06 EPS for the current fiscal year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.